Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. Its structure supports binding to enzyme active sites, making it valuable in designing drugs that target specific signaling pathways in tumor cells. Also employed in research for antiviral agents due to its similarity to purine bases. Commonly modified at the amino group to enhance potency and selectivity in drug candidates.